Literature DB >> 29410404

A microengineered vascularized bleeding model that integrates the principal components of hemostasis.

Yumiko Sakurai1,2, Elaissa T Hardy1,2, Byungwook Ahn1,2, Reginald Tran1,2, Meredith E Fay1,2, Jordan C Ciciliano3, Robert G Mannino1,2, David R Myers1,2, Yongzhi Qiu1,2, Marcus A Carden2, W Hunter Baldwin2, Shannon L Meeks2, Gary E Gilbert4, Shawn M Jobe5, Wilbur A Lam6,7.   

Abstract

Hemostasis encompasses an ensemble of interactions among platelets, coagulation factors, blood cells, endothelium, and hemodynamic forces, but current assays assess only isolated aspects of this complex process. Accordingly, here we develop a comprehensive in vitro mechanical injury bleeding model comprising an "endothelialized" microfluidic system coupled with a microengineered pneumatic valve that induces a vascular "injury". With perfusion of whole blood, hemostatic plug formation is visualized and "in vitro bleeding time" is measured. We investigate the interaction of different components of hemostasis, gaining insight into several unresolved hematologic issues. Specifically, we visualize and quantitatively demonstrate: the effect of anti-platelet agent on clot contraction and hemostatic plug formation, that von Willebrand factor is essential for hemostasis at high shear, that hemophilia A blood confers unstable hemostatic plug formation and altered fibrin architecture, and the importance of endothelial phosphatidylserine in hemostasis. These results establish the versatility and clinical utility of our microfluidic bleeding model.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29410404      PMCID: PMC5802762          DOI: 10.1038/s41467-018-02990-x

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  36 in total

1.  Microfluidic large-scale integration.

Authors:  Todd Thorsen; Sebastian J Maerkl; Stephen R Quake
Journal:  Science       Date:  2002-09-26       Impact factor: 47.728

2.  A systems approach to hemostasis: 4. How hemostatic thrombi limit the loss of plasma-borne molecules from the microvasculature.

Authors:  John D Welsh; Ryan W Muthard; Timothy J Stalker; Joshua P Taliaferro; Scott L Diamond; Lawrence F Brass
Journal:  Blood       Date:  2016-01-06       Impact factor: 22.113

3.  Procoagulant platelets form an α-granule protein-covered "cap" on their surface that promotes their attachment to aggregates.

Authors:  Anastasia A Abaeva; Matthias Canault; Yana N Kotova; Sergey I Obydennyy; Alena O Yakimenko; Nadezhda A Podoplelova; Vladimir N Kolyadko; Herve Chambost; Aleksei V Mazurov; Fazoil I Ataullakhanov; Alan T Nurden; Marie-Christine Alessi; Mikhail A Panteleev
Journal:  J Biol Chem       Date:  2013-08-30       Impact factor: 5.157

4.  New insights into the spatiotemporal localization of prothrombinase in vivo.

Authors:  Lacramioara Ivanciu; Sriram Krishnaswamy; Rodney M Camire
Journal:  Blood       Date:  2014-05-28       Impact factor: 22.113

5.  Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets.

Authors:  C A Hillery; D J Mancuso; J Evan Sadler; J W Ponder; M A Jozwiak; P A Christopherson; J Cox Gill; J Paul Scott; R R Montgomery
Journal:  Blood       Date:  1998-03-01       Impact factor: 22.113

Review 6.  Tissue-specific hemostasis in mice.

Authors:  Nigel Mackman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-08-25       Impact factor: 8.311

7.  Genomic responses in mouse models poorly mimic human inflammatory diseases.

Authors:  Junhee Seok; H Shaw Warren; Alex G Cuenca; Michael N Mindrinos; Henry V Baker; Weihong Xu; Daniel R Richards; Grace P McDonald-Smith; Hong Gao; Laura Hennessy; Celeste C Finnerty; Cecilia M López; Shari Honari; Ernest E Moore; Joseph P Minei; Joseph Cuschieri; Paul E Bankey; Jeffrey L Johnson; Jason Sperry; Avery B Nathens; Timothy R Billiar; Michael A West; Marc G Jeschke; Matthew B Klein; Richard L Gamelli; Nicole S Gibran; Bernard H Brownstein; Carol Miller-Graziano; Steve E Calvano; Philip H Mason; J Perren Cobb; Laurence G Rahme; Stephen F Lowry; Ronald V Maier; Lyle L Moldawer; David N Herndon; Ronald W Davis; Wenzhong Xiao; Ronald G Tompkins
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-11       Impact factor: 11.205

Review 8.  Eptifibatide: a potent inhibitor of the platelet receptor integrin glycoprotein IIb/IIIa.

Authors:  J Conor O'Shea; James E Tcheng
Journal:  Expert Opin Pharmacother       Date:  2002-08       Impact factor: 3.889

Review 9.  Microfluidic technology as an emerging clinical tool to evaluate thrombosis and hemostasis.

Authors:  Brian R Branchford; Christopher J Ng; Keith B Neeves; Jorge Di Paola
Journal:  Thromb Res       Date:  2015-05-21       Impact factor: 3.944

Review 10.  The use of microfluidics in hemostasis: clinical diagnostics and biomimetic models of vascular injury.

Authors:  Keith B Neeves; Abimbola A Onasoga; Adam R Wufsus
Journal:  Curr Opin Hematol       Date:  2013-09       Impact factor: 3.284

View more
  25 in total

1.  Endothelial cell culture in microfluidic devices for investigating microvascular processes.

Authors:  Robert G Mannino; Yongzhi Qiu; Wilbur A Lam
Journal:  Biomicrofluidics       Date:  2018-05-15       Impact factor: 2.800

Review 2.  Getting a good view: in vitro imaging of platelets under flow.

Authors:  Oluwamayokun Oshinowo; Tamara Lambert; Yumiko Sakurai; Renee Copeland; Caroline E Hansen; Wilbur A Lam; David R Myers
Journal:  Platelets       Date:  2020-02-28       Impact factor: 3.862

3.  von Willebrand factor binding to myosin assists in coagulation.

Authors:  Veronica H Flood; Tricia L Slobodianuk; Daniel Keesler; Hannah K Lohmeier; Scot Fahs; Liyun Zhang; Pippa Simpson; Robert R Montgomery
Journal:  Blood Adv       Date:  2020-01-14

4.  Organ-on-chips made of blood: endothelial progenitor cells from blood reconstitute vascular thromboinflammation in vessel-chips.

Authors:  Tanmay Mathur; Kanwar Abhay Singh; Navaneeth K R Pandian; Shu-Huai Tsai; Travis W Hein; Akhilesh K Gaharwar; Jonathan M Flanagan; Abhishek Jain
Journal:  Lab Chip       Date:  2019-07-23       Impact factor: 6.799

5.  Roadmap on nanomedicine.

Authors:  Paolo Decuzzi; Dan Peer; Daniele Di Mascolo; Anna Lisa Palange; Purnima Naresh Manghnani; S Moein Moghimi; Z Shadi Farhangrazi; Kenneth A Howard; Daniel Rosenblum; Tingxizi Liang; Zhaowei Chen; Zejun Wang; Jun-Jie Zhu; Zhen Gu; Netanel Korin; Didier Letourneur; Cédric Chauvierre; Roy van der Meel; Fabian Kiessling; Twan Lammers
Journal:  Nanotechnology       Date:  2021-01-01       Impact factor: 3.874

Review 6.  Hyperviscosity syndromes; hemorheology for physicians and the use of microfluidic devices.

Authors:  Jamie O Musick; Kirby S Fibben; Wilbur A Lam
Journal:  Curr Opin Hematol       Date:  2022-07-18       Impact factor: 3.218

7.  Red Blood Cell Adhesion to Heme-Activated Endothelial Cells Reflects Clinical Phenotype in Sickle Cell Disease.

Authors:  Erdem Kucukal; Anton Ilich; Nigel S Key; Jane A Little; Umut A Gurkan
Journal:  Am J Hematol       Date:  2018-06-15       Impact factor: 10.047

Review 8.  Microphysiological systems for the modeling of wound healing and evaluation of pro-healing therapies.

Authors:  Halston E Deal; Ashley C Brown; Michael A Daniele
Journal:  J Mater Chem B       Date:  2020-08-19       Impact factor: 6.331

Review 9.  The effect of platelet storage temperature on haemostatic, immune, and endothelial function: potential for personalised medicine.

Authors:  Susan M Shea; Kimberly A Thomas; Philip C Spinella
Journal:  Blood Transfus       Date:  2019-07       Impact factor: 3.443

10.  A Human Vascular Injury-on-a-Chip Model of Hemostasis.

Authors:  Izmarie Poventud-Fuentes; Keon Woo Kwon; Jeongyun Seo; Maurizio Tomaiuolo; Timothy J Stalker; Lawrence F Brass; Dongeun Huh
Journal:  Small       Date:  2020-11-04       Impact factor: 13.281

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.